@article{caa556f111c24737ba0e8347c66ae7c9,
title = "Nationwide surveillance of antimicrobial resistance among clinically important Gram-negative bacteria, with an emphasis on carbapenems and colistin: Results from the Surveillance of Multicenter Antimicrobial Resistance in Taiwan (SMART) in 2018",
abstract = "Multicentre surveillance of antimicrobial susceptibility of clinically important Gram-negative bacteria (GNB) from 16 Taiwanese hospitals was performed. Escherichia coli (n = 398), Klebsiella pneumoniae (n = 346), Pseudomonas aeruginosa (n = 252) and Acinetobacter baumannii complex (ABC) (n = 188) bloodstream isolates, non-typhoidal Salmonella (n = 230) and Shigella flexneri (n = 18) from various sources were collected. Antimicrobial MICs were determined using broth microdilution. Genes encoding K. pneumoniae carbapenemases (KPCs), New Delhi metallo-β-lactamases (NDMs), Verona integron-encoded metallo-β-lactamase (VIM), OXA-48-like carbapenemase (OXA-48) as well as mcr-1–5 genes were detected by molecular methods. Rates of carbapenem non-susceptibility were 2.8%, 9.0%, 0.4%, 0%, 10.3% and 48.8% for E. coli, K. pneumoniae, Salmonella, Shigella, P. aeruginosa and ABC, respectively. For carbapenemases, one (0.3%) E. coli harboured blaNDM-1. Fifteen (4.3%), two (0.6%) and two (0.6%) K. pneumoniae contained blaKPC, blaOXA-48 and blaVIM, respectively. Two (0.5%) E. coli and fourteen (4.0%) K. pneumoniae were non-wild-type according to the colistin MIC. Among Enterobacteriaceae with a colistin MIC ≥ 2 mg/L, mcr-1 was detected in one E. coli, two K. pneumoniae and three Salmonella spp. All three mcr-1-positive Salmonella isolates were collected from community-acquired infections; none of the six mcr-1-positive Enterobacteriaceae were carbapenem-resistant. Carbapenem resistance has increased among clinically important GNB, especially among hospital-acquired infections. blaKPC, especially the blaKPC-2 variant, was detected in approximately one-half of the carbapenem-resistant K. pneumoniae isolates in this study. Although resistance rates to colistin remained low among Enterobacteriaceae, the finding of mcr-1 from different species raises concern of potential dissemination.",
keywords = "Carbapenemase, Colistin, Enterobacteriaceae, KPC, mcr-1",
author = "Lee, {Yu Lin} and Lu, {Min Chi} and Shao, {Pei Lan} and Lu, {Po Liang} and Chen, {Yen Hsu} and Cheng, {Shu Hsing} and Ko, {Wen Chien} and Lin, {Chi Ying} and Wu, {Ting Shu} and Yen, {Muh Yong} and Wang, {Lih Shinn} and Liu, {Chang Pan} and Lee, {Wen Sen} and Shi, {Zhi Yuan} and Chen, {Yao Shen} and Wang, {Fu Der} and Tseng, {Shu Hui} and Lin, {Chao Nan} and Chen, {Yu Hui} and Sheng, {Wang Huei} and Lee, {Chun Ming} and Liao, {Ming Huei} and Hsueh, {Po Ren}",
note = "Funding Information: The authors thank all of the investigators of the participating hospitals for their co-operation and support in the Surveillance of Multicenter Antimicrobial Resistance in Taiwan (SMART) programme in 2018. This work was supported by grants from the Taiwan Centers for Disease Control and Prevention, Minister of Health and Welfare, Executive Yuan, Taiwan [MOHW106-CDC-C-114-114701]. This study was approved by the Research Ethics Committees or Institutional Review Boards of the 16 participating hospitals. The requirement for informed consent from each patient was waived. Investigators from the SMART programme 2018 were as follows: Shio-Shin Jean (Wan Fang Hospital, Taipei), Wen-Sen Lee (Wan Fang Hospital, Taipei), Min-Chi Lu (China Medical University Hospital, Taichung), Zhi-Yuan Shi (Taichung Veterans General Hospital, Taichung), Yao-Shen Chen (Kaohsiung Veterans General Hospital, Kaohsiung), Lih-Shinn Wang (Buddhist Tzu Chi General Hospital, Hualien), Shu-Hui Tseng (Ministry of Health and Welfare, Taipei), Chao-Nan Lin (National Pingtung University of Science and Technology, Pingtung), Yin-Ching Chuang (Chi Mei Hospital, Tainan), Yu-Hui Chen (Chi Mei Hospital, Tainan), Wang-Huei Sheng (National Taiwan University Hospital, Taipei), Chang-Pan Liu (MacKay Memorial Hospital, Taipei), Ting-Shu Wu (Chang Gung Memorial Hospital, Taoyuan), Chun-Ming Lee (St Joseph's Hospital, Yunlin), Po-Liang Lu (Kaohsiung Medical University Hospital, Kaohsiung), Muh-Yong Yen (Taipei City Hospital, Taipei), Pei-Lan Shao (National Taiwan University Hospital, Hsin-Chu), Shu-Hsing Cheng (Taoyuan General Hospital, Taoyuan), Chi-Ying Lin (National Taiwan University Hospital, Yun-Lin), Ming-Huei Liao (National Pingtung University of Science and Technology, Pingtung), Yen-Hsu Chen (Kaohsiung Medical University, Kaohsiung), Wen-Chien Ko (National Cheng Kung University Hospital, Tainan), Fu-Der Wang (Taipei Veterans General Hospital, Taipei) and Po-Ren Hsueh (National Taiwan University Hospital, Taipei). Funding Information: This work was supported by grants from the Taiwan Centers for Disease Control and Prevention, Minister of Health and Welfare , Executive Yuan, Taiwan [ MOHW106-CDC-C-114-114701 ]. Publisher Copyright: {\textcopyright} 2019",
year = "2019",
month = sep,
doi = "10.1016/j.ijantimicag.2019.06.009",
language = "English",
volume = "54",
pages = "318--328",
journal = "International Journal of Antimicrobial Agents",
issn = "0924-8579",
publisher = "Elsevier",
number = "3",
}